Free Trial

Citigroup Issues Positive Forecast for AMETEK (NYSE:AME) Stock Price

AMETEK logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Citigroup raised its AMETEK price target to $270 from $263 but maintained a neutral rating, implying 13.78% upside from the prior close. Analysts overall have a “Moderate Buy” consensus and an average target of $278.06.
  • AMETEK beat quarterly estimates, reporting EPS of $2.21 versus $2.11 expected and revenue of $2.22 billion versus $2.12 billion; revenue grew 17.3% year over year.
  • Despite the earnings beat, AMETEK shares fell 4.5% on Wednesday to $237.29.
  • Five stocks to consider instead of AMETEK.

AMETEK (NYSE:AME - Get Free Report) had its price objective upped by equities researchers at Citigroup from $263.00 to $270.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a "neutral" rating on the technology company's stock. Citigroup's price target would indicate a potential upside of 13.78% from the company's previous close.

A number of other research firms also recently issued reports on AME. Deutsche Bank Aktiengesellschaft lifted their target price on AMETEK from $288.00 to $318.00 and gave the company a "buy" rating in a research report on Wednesday, September 30th. Vertical Research initiated coverage on AMETEK in a research note on Tuesday, September 8th. They issued a "buy" rating and a $255.00 price target for the company. Zacks Research raised AMETEK from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, October 6th. Seaport Research Partners increased their price objective on AMETEK from $290.00 to $300.00 and gave the company a "buy" rating in a report on Wednesday, September 2nd. Finally, Truist Financial raised their target price on shares of AMETEK from $303.00 to $316.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $278.06.

View Our Latest Stock Analysis on AMETEK

AMETEK Stock Down 4.5%

AME traded down $11.29 during trading hours on Wednesday, hitting $237.29. 2,778,916 shares of the company's stock were exchanged, compared to its average volume of 1,325,307. The stock has a market cap of $54.39 billion, a price-to-earnings ratio of 34.69, a PEG ratio of 2.29 and a beta of 0.96. AMETEK has a 1-year low of $188.47 and a 1-year high of $261.16. The stock's 50-day moving average is $243.74 and its two-hundred day moving average is $234.40. The company has a quick ratio of 0.76, a current ratio of 1.21 and a debt-to-equity ratio of 0.09.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The technology company reported $2.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.11 by $0.10. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The firm had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.12 billion. During the same period in the previous year, the business earned $1.89 EPS. The company's revenue was up 17.3% compared to the same quarter last year. Sell-side analysts predict that AMETEK will post 8.41 earnings per share for the current fiscal year.

Insider Transactions at AMETEK

In other news, insider David Hermance sold 6,608 shares of the firm's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the sale, the insider directly owned 42,509 shares of the company's stock, valued at $10,797,286. This trade represents a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.54% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Running Oak Capital LLC increased its holdings in AMETEK by 2.2% in the third quarter. Running Oak Capital LLC now owns 48,864 shares of the technology company's stock worth $12,105,000 after purchasing an additional 1,033 shares in the last quarter. Fulcrum Asset Management LLP boosted its holdings in shares of AMETEK by 2.8% during the 3rd quarter. Fulcrum Asset Management LLP now owns 20,290 shares of the technology company's stock worth $5,088,000 after buying an additional 562 shares in the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of AMETEK by 0.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 157,126 shares of the technology company's stock worth $39,138,000 after buying an additional 866 shares during the period. Hohimer Wealth Management LLC grew its position in shares of AMETEK by 6.1% during the 3rd quarter. Hohimer Wealth Management LLC now owns 3,224 shares of the technology company's stock worth $799,000 after buying an additional 186 shares during the period. Finally, Brighton Jones LLC increased its stake in shares of AMETEK by 25.8% in the 3rd quarter. Brighton Jones LLC now owns 8,156 shares of the technology company's stock valued at $2,020,000 after acquiring an additional 1,672 shares in the last quarter. 87.43% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting AMETEK

Here are the key news stories impacting AMETEK this week:

  • Positive Sentiment: AMETEK reported Q3 EPS of $2.21, above the roughly $2.11 consensus, and revenue of $2.22 billion versus estimates of $2.12 billion. Revenue grew 17.3% year over year. Organic sales growth, margin expansion and a record backlog supported higher 2026 earnings and free-cash-flow guidance. AMETEK Q3 Earnings Beat Estimates on Organic Sales & Margin Gains
  • Positive Sentiment: The company’s 2026 EPS outlook is reported at $8.53–$8.57, with management targeting mid-teens sales growth following the Indicor close—an additional indication of confidence in its growth outlook. AMETEK forecasts 2026 EPS of $8.53-$8.57
  • Neutral Sentiment: Mizuho cut its price target to $275 from $285 but retained an Outperform rating. The lower target is a modest negative revision, while the maintained rating signals continued analyst optimism. Mizuho stock recommendations
  • Neutral Sentiment: A broader industrial-sector article raises questions about whether debt could constrain future dividend increases. The item does not identify a specific AMETEK debt or dividend problem. Can industrial dividends keep growing?

About AMETEK

(Get Free Report)

AMETEK, Inc is a global manufacturer of industrial technology solutions. The company develops and produces advanced analytical, monitoring, testing, and measurement instruments, as well as engineered electromechanical products used in industrial, aerospace, defense, energy, medical, and other specialized markets.

AMETEK operates through two primary business groups: Electronic Instruments and Electromechanical. Its products include process and power monitoring systems, analytical instruments, automation and control technologies, aerospace and defense equipment, precision motion-control systems, motors, thermal-management solutions, engineered materials, and specialty metal products.

The company traces its roots to 1930 and has expanded through the development and acquisition of specialized technology businesses.

See Also

Analyst Recommendations for AMETEK (NYSE:AME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AMETEK Right Now?

Before you consider AMETEK, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.

While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines